HISTORY

UNEEG medical A/S was founded in 2005 by Professor dr. med. Henning Beck-Nielsen and co-Founder M.Sc.Eng. Rasmus Stig Jensen. Originally the company’s aim was to build disruptive technologies for insulin dependent diabetics, that prior to severe hypoglycemia should receive an alert, hence aiming at improving patients’ quality of life and personal safety.

In 2009 T&W Medical A/S became the majority shareholder of the company. Chairman of the board is Søren Westermann, who represents one part of the two families, Tøpholm and Westermann. Both families are through T&W Medical A/S co-owners of WS Audiology A/S, a merger between former Widex A/S and Sivantos Pte. Ltd. WS Audiology A/S is a sister company to UNEEG medical. The group of owners also includes Hera Holding ApS.

Today, UNEEG medical employs approximately 60 people and is facing an international market launch.

Richard Tøpholm

Richard Tøpholm is CEO at T&W Engineering A/S, a company closely related to UNEEG™ medical A/S which forms the EEG Group majority owned by T&W Medical A/S – formerly known as Widex Holding. Richard has worked as an electrical engineer in various functions at Widex since 1992, covering Algorithm Design, 3D Scanner development, Building Automation and Energy Systems, Production Automation, Project Portfolio Management and more.

Since 2013 Richard has headed up the Widex EEG development team. Ultra-long-term EEG has been an active development area at Widex since 2006 and was spun out into a separate business unit in 2015. Richard has been on the Widex Board of Directors in the period 2011-2019, until Widex A/S merged with Sivantos forming the sister company WS Audiology. Further, he is on the UNEEG™ medical A/S’ Board of Directors since 2009 and Copenhagen Atomics Board of Directors since 2018. He holds an MSc.E. in Electrical Engineering from DTU with focus on Applied Physics, Psycho Acoustics, Control Theory & Automation and Space & Satellite design.
 

Henning Beck-Nielsen

Henning Beck-Nielsen is Founder and shareholder, CMO
and Vice-chair of the Board at UNEEG medical. Henning is a professor of Diabetes at University of Southern Denmark & University of Copenhagen. He is a trained diabetologist with a special interest in Hypoglycaemia. He previously headed Department of Endocrinology & the research unit at Odense University Hospital and he is as such an experienced scientist with more than 600
peer-reviewed publications. Henning is known and respected for his lifelong efforts in diabetes care and he was a major driver of the creation of the Danish Diabetes Academy,
where he also resided as the first president.

Henning has received several scientific prizes and awards, among others the two most prestigious awards in Denmark, namely, the Hagedorn Prize and the Novo Nordisk Award. 

Rasmus Stig Jensen

Rasmus Stig Jensen is Co-founder of UNEEG medical A/S and has been running the company as CEO until 2018, where he changed to a role focusing mainly on his passion for product development. Rasmus has approximately 25 years of experience in entrepreneurship and project management of large-scale, cross-border R&D projects and client/supplier contracts. Among those, Rasmus has 20 years of experience in line management and project portfolio management in large industrial companies such as Ansaldo and Alfa Laval.

Rasmus has an educational background as Engineer from Aalborg University and L’Univercité de Technologie de Compiègne and holds among others a Graduate Certificate in Medical Device Regulatory Affairs and Business, from North Eastern University.